Late-Stage Success Raises Hopes to Tackle Alzheimer’s via Inflammation,

Last week, AB Science reported successful results from a phase IIb/III clinical trial testing its drug masitinib in patients with mild to moderate symptoms …, Last week, AB Science reported successful results from a phase IIb/III clinical trial testing its drug masitinib in patients with mild to moderate symptoms …, Read More

Scroll to Top